Paroxetine hydrochloride compound and synthetic method thereof

A technology of paroxetine hydrochloride and paroxetine methyl, which is applied in the field of medicine, can solve problems such as unfavorable removal of organic solvents, poor stability of chloroformic acid-α-chloroethyl ester, complicated operation, etc., and achieve mild production conditions and good stability , the effect of high total yield

Active Publication Date: 2012-10-10
ZHEJIANG JIANFENG PHARM CO LTD
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the original process, chloroformic acid-α-chloroethyl was used as a demethylation reagent. In the synthesis of this reagent, freshly distilled thionyl chloride was used. The operation was complicated, and the synthesized chloroformic acid-α-chloroethyl had poor stability, and the yield was about 67%
[0006] Chinese invention patent application (application number: 200810104136.1 application date: 2008-04-16) discloses a preparation method of paroxetine hydrochloride and its intermediates. Using a compound of structural formula (II) to prepare a compound of structural formula (I), and then preparing paroxetine, this method involves a variety of organic solvents, which is not conducive to the removal of organic solvents;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Paroxetine hydrochloride compound and synthetic method thereof
  • Paroxetine hydrochloride compound and synthetic method thereof
  • Paroxetine hydrochloride compound and synthetic method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Synthetic process and refining method of paroxetine hydrochloride

[0031] 1) Preparation of crude paroxetine hydrochloride:

[0032] Such as figure 2 As shown, add 20 kg of N-methylparoxetine into 290 kg of toluene, stir, add ethyl chloroformate toluene mixture dropwise at room temperature, after the addition, stir for 30 minutes, heat up to 60-70 ° C, keep stirring for 4- After 6 hours (TLC detected that the reaction was complete, petroleum ether: ethyl acetate = 3:1), the organic layer was washed with water and aqueous sodium bicarbonate solution respectively, the water layer was separated, and the toluene was concentrated under reduced pressure to obtain a viscous substance.

[0033] N-methylparoxetine, source: Linhai Jinqiao Chemical Factory

[0034]

[0035] Add 700kg of ethanol to the residue, add 70.0Kg of potassium hydroxide, and heat up and reflux for 20-25 hours (about 80°C) (TLC test shows that the reaction is complete, if the reaction is too slow, add...

Embodiment 1 3

[0043] The stability situation of embodiment 1 three batches of samples is as follows:

[0044] Stability inspection items: selected according to the key inspection items stipulated in the above guiding principles and the properties of this variety, mainly including appearance, pH, moisture, related substances, and content.

[0045] Inspection basis: According to the 2010 edition of the Pharmacopoeia standard of paroxetine hydrochloride

[0046] Sample: three batches of 100401, 100402, and 100403 produced in Example 1.

[0047] accelerated test

[0048] Test method: Take this product to simulate the packaging of the marketed drug, and place it at 40 ° C ± 2 o C Place it under the condition of relative humidity RH75%±5% for 6 months. Samples were taken at 0, 1, 2, 3 and 6 months, and the indicators measured were compared with the samples at 0. The test results are shown in Table 1.

[0049] The accelerated test was carried out for 6 months, and the test results showed tha...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicine and particularly relates to a paroxetine hydrochloride compound and a synthetic method thereof. The paroxetine hydrochloride compound has the following structural formula. According to the paroxetine hydrochloride compound, ethyl chloroformate for industrial production is used as a demethylation reagent, the reagent is stable, the production condition of demethylation is moderate, the total yield is high and about 75%, and the paroxetine hydrochloride compound accords with the requirement of a 2010 edition of a pharmacopeia and applicable to industrial production.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a paroxetine hydrochloride compound and a synthesis method thereof. Background technique [0002] Paroxetine hydrochloride, chemical name: (-)-(3S,4R)-4-(fluorophenyl)-3-{[3,4-(methylenedioxy)phenoxy]methyl}-piperidine Hydrochloride hemihydrate. Its structural formula is as follows: [0003] ; [0004] It is suitable for the treatment of various depressions. Includes depression with anxiety and reactive depression, panic disorder with or without agoraphobia, and obsessive-compulsive disorder. [0005] In the existing paroxetine hydrochloride process, p-fluorobenzaldehyde is used as the starting raw material, and methyl paroxetine hydrochloride is generated through five-step reactions, and then paroxetine hydrochloride is generated through demethylation reaction, and the specific route is as follows figure 1 . Using p-fluorobenzaldehyde as the starting material, it undergoes a five...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D405/12
Inventor 蒋晓萌黄金龙施存元张孝君蔡月苹
Owner ZHEJIANG JIANFENG PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products